Titan Medical Inc. (TMD.TO)
| Previous Close | 0.5800 |
| Open | 0.5800 |
| Bid | 0.5500 x 0 |
| Ask | 0.6000 x 0 |
| Day's Range | 0.5600 - 0.5900 |
| 52 Week Range | 0.4900 - 2.5900 |
| Volume | |
| Avg. Volume | 31,982 |
| Market Cap | 63.386M |
| Beta (5Y Monthly) | 4.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1080 |
| Earnings Date | Aug 09, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Titan Medical to Present at the H.C. Wainwright Global Investment Conference
TORONTO, May 18, 2022--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced the company will present an overview of its Enos™ robotic single access surgical system at the H.C. Wainwright Global Investment Conference, taking place May 23-26, 2022 at the Fontainebleau Miami Beach Hotel in Miami, Florida.
- Business Wire
Titan Medical Reports Financial Results for the First Quarter 2022
TORONTO, May 12, 2022--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022.
- Business Wire
Titan Medical Announces Availability of Materials for the 2022 Annual and Special Meeting of Shareholders
TORONTO, May 06, 2022--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that its 2022 Annual and Special Meeting ("the Meeting") is scheduled for Wednesday, June 8, 2022 at 4:00 p.m. ET to be held virtually at https://web.lumiagm.com/432237190.
